AT/AU

(redirected from Alopecia Totalis and Alopecia Universalis)
AcronymDefinition
AT/AUAlopecia Totalis and Alopecia Universalis (hair loss)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
The responders in the 8 mg twice-daily dose group were evenly distributed among patients with patchy alopecia areata and the more severe forms, alopecia totalis and alopecia universalis.
The responders in the 8 mg twice-daily dose group were evenly distributed among patients with patchy alopecia areata and the more severe forms, alopecia totalis and alopecia universalis. The percentage of patients achieving the primary endpoint continued to increase up to Week 24, and regrowth of hair did not appear to plateau at Week 24.
Scalp is the most common affected site.4 Alopecia areata can be classified according to its pattern, as follows: patchy, reticular, ophiasis, sisaipho, alopecia totalis and alopecia universalis. Patchy type is the most common.
The United States Food and Drug Administration has approved the 30-day review period for US-based Aclaris Therapeutics' investigational new drug application for ATI-50001, an orally administered investigational Janus Kinase inhibitor, intended for the potential treatment of alopecia totalis and alopecia universalis, it was reported on Thursdau.
The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J.
Aclaris Therapeutics announced that the first patient has been dosed in Aclaris' Phase 2 clinical trial of its JAK inhibitor product candidate ATI-501 oral suspension in patients with two forms of Alopecia Areata known as Alopecia Totalis and Alopecia Universalis. AA is an autoimmune dermatologic condition typically characterized by patchy non-scarring hair loss on the scalp and body.
60% patients were of extensive AA, and 20% each of alopecia totalis and alopecia universalis. Age and gender distribution is shown in Table 2.